fasudil has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, J | 1 |
| Xi, JY | 1 |
| Yu, WB | 1 |
| Yan, C | 1 |
| Luo, SS | 1 |
| Zhou, L | 1 |
| Zhu, WH | 1 |
| Lu, JH | 1 |
| Dong, Q | 1 |
| Xiao, BG | 1 |
| Zhao, CB | 1 |
1 other study available for fasudil and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cells, Cultured; Disease Models, Animal; Fem | 2019 |